HbA1c and peripheral arterial disease in diabetes: The atherosclerosis risk in communities study

Diabetes Care

Volumn 29, Issue 4, 2006, Pages 877-882

  Selvin, Elizabeth ^a,b   Wattanakit, Keattiyoat ^c   Steffes, Michael W ^d   Coresh, Josef ^a,b   Sharrett, A Richey ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AFRICAN AMERICAN; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SYMPTOMATOLOGY; BLOOD; DIABETIC ANGIOPATHY; EDUCATIONAL STATUS; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; PROSPECTIVE STUDY; RISK FACTOR; SMOKING;

COHORT STUDIES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; EDUCATIONAL STATUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 33746330460     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.04.06.dc05-2018     Document Type: Article

References (32)

1. Selvin E, Erlinger TP: Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey,1999-2000. Circulation 110:738-743, 2004
2. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, Burt V, Curtin L, Engelgau M, Geiss L, the 1999-2000 National Health and Nutrition Examination Survey: Prevalence of lower-extremity disease in the U.S. adult population ≥40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care 27:1591-1597, 2004
3. Murabito JM, Evans JC, Larson MG, Nieto K, Levy D, Wilson PWF: The Ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med 163:1939-1942, 2003
4. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D: Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 19:538-545, 1999
5. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381-386, 1992
6. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
7. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
8. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421-431, 2004
9. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000
10. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW: Glycemic control and coronary heart disease risk in persons with and without diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med 165:1910-1916, 2005
11. Lehto S, Ronnemaa T, Pyorala K, Laakso M: Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 19:607-612, 1996
12. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR: UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25:894-899, 2002
13. Moss SE, Klein R, Klein BE: The 14-year incidence of lower-extremity amputations in a diabetic population: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 22:951-959, 1999
14. The ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives.AmJ Epidemiol 129:687-702, 1989
15. Jackson R, Chambless LE, Yang K, Byrne T, Watson R, Folsom A, Shahar E, Kalsbeek W: Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity: the Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol 49:1441-1446, 1996
16. Operations Manual no. 10: Clinical Chemistry Determinations. Version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina, 1987
17. Vitelli LL, Shahar E, Heiss G, McGovern PG, Brancati FL, Eckfeldt JH, Folsom AR: Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals: the Atherosclerosis Risk in Communities Study. Diabetes Care 20:1454-1458, 1997
18. Selvin E, Coresh J, Jordahl J, Boland L, Steffes MW: Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade. Diabet Med 22:1726-1730, 2005
19. Rose GA, Gillum RF, Prineas RJ: Cardiovascular Survey Methods. Geneva, World Health Org., 1982
20. Mundt KA, Chambless LE, Burnham CB, Heiss G: Measuring ankle systolic blood pressure: validation of the Dinamap 1846 SX. Angiology 43:555-566, 1992
21. ARIC: Atherosclerosis Risk in Communities Study: Manual 11: Sitting Blood Pressure and Postural Changes in Blood Pressure and Heart Rate. Chapel Hill, NC, National Heart, Lung, and Blood Institute, 1987
22. ARIC: Atherosclerosis Risk in Communities Study: Manual 6A: Ultrasound Assessment. Chapel Hill, NC, National Heart, Lung, and Blood Institute, 1987
23. Lijmer JG, Hunink MG, van den Dungen JJ, Loonstra J, Smit AJ: ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 22:391-398, 1996
24. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW: Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075-1080, 1983
25. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W: Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 22:165-174, 1984
26. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
27. ARIC Coordinating Center: Operations Manual no. 2: Cohort Component Procedures. Version 1.0. Chapel Hill, NC, School of Public Health, University of North Carolina, 1987
28. Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett AR: Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol 4:821-826, 2005
29. Selvin E, Coresh J, Golden SH, Boland LL, Brancati FL, Steffes MW: Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 28:1965-1973, 2005
30. Yodaiken RE: The relationship between diabetic capillaropathy and myocardial infarction: a hypothesis. Diabetes 25 (Suppl. 2):928-930, 1976
31. Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 13:513-521, 1990
32. Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S: The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 71:516-522, 1985